Medibank Pvt (FRA:MPV) Tariff Resilience Score: 9/10 (As of Jul. 02, 2026)


FRA:MPV Medibank Pvt Ltd FRA:MPV
76 GF Score
Price €2.96
GF Value €2.61
! 6 Warning Signs
View Full Analysis

What is Medibank Pvt Tariff Resilience Score?

Medibank Pvt FRA:MPV 76 Tariff Resilience Score is 9 as of Jul. 02, 2026. GuruFocus rates FRA:MPV with a GF Score™ of 76/100 and a GF Value™ of €2.61. The stock has 6 warning signs investors should review. Among 597 Insurance companies, Medibank Pvt ranks better than 99.66% on this metric.

Medibank Pvt has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

Medibank Pvt has Healthcare insurance with operations primarily in Australia. Minimal exposure to international tariffs due to domestic focus.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Medibank Pvt might have Highly Resilient.

Medibank Pvt  (FRA:MPV) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Medibank Pvt Tariff Resilience Score Related Terms

FRA:MPV vs FNF, AXS, FAF: Tariff Resilience Score Comparison

For the Insurance - Specialty subindustry, Medibank Pvt's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medibank Pvt Tariff Resilience Score vs Insurance Industry

For the Insurance industry and Financial Services sector, Medibank Pvt's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Medibank Pvt's Tariff Resilience Score falls into.


FRA:MPV
76GF Score
Medibank Pvt Ltd FRA:MPV
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
Medibank Pvt (FRA:MPV) has a Tariff Resilience Score of 9 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Medibank Pvt ranks #2 out of 597 companies in the Insurance industry, placing it in the top 0.3%.
Is Medibank Pvt's Tariff Resilience Score too high?
Medibank Pvt's current Tariff Resilience Score is 9. Based on the distribution chart, Medibank Pvt ranks #2 out of 597 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Medibank Pvt has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's Tariff Resilience Score compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #2 out of 597 companies for Tariff Resilience Score. This places Medibank Pvt in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for an Insurance company?
A good Tariff Resilience Score depends on the Insurance industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Medibank Pvt's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Medibank Pvt (FRA:MPV) has a current Tariff Resilience Score of 9. The stock's GF Value™ is €2.61, compared to a current price of €2.96 — trading 13.4% above its estimated fair value. The current Tariff Resilience Score is 9. Medibank Pvt's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Medibank Pvt (FRA:MPV), the current Tariff Resilience Score is 9 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medibank Pvt (FRA:MPV) Overvalued in 2026?

Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued. The current stock price of €2.96 is trading 13.4% above its estimated GF Value™ of €2.61.

Key valuation signals for FRA:MPV:

  • Tariff Resilience Score: 9
  • GF Value™: €2.61 vs. price of €2.96 (13.4% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the FRA:MPV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medibank Pvt Business Description

Address 695 Collins Street, Medibank Melbourne Hub, Level 2, Docklands, Melbourne, VIC, AUS, 3008
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
76GF Score

Get the complete analysis for FRA:MPV

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.96
Price
€2.61
GF Value